Company Overview and News

0
Srei Infra Finance files insolvency plea against two Sandesara firms

2018-06-26 livemint
Mumbai: Srei Infrastructure Finance Ltd has filed an insolvency petition against Sterling SEZ & Infrastructure and Sterling International Enterprises before the Mumbai bench of the National Company Law Tribunal (NCLT).
SIFLY 508998 523756 STEERINTER SRI SLTHY STERLINBIO SREINFRA 512299 532418 SRIA ANDHRABANK

0
Andhra Bank moves NCLT to recover Rs 4,000-crore Sterling Biotech dues

2018-06-12 freepressjournal.in
Mumbai : The National Company Law Tribunal (NCLT) on Monday admitted an insolvency plea filed by Andhra Bank against Sterling Biotech, seeking recovery of Rs 4,000 crore in dues.
SLTHY STERLINBIO 512299 532418 ANDHRABANK

0
Sterling Biotech Limited - News Clarification

2018-06-01 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
SLTHY STERLINBIO 512299

2
Bank fraud: ED attaches Rs 4,701 crore assets of Gujarat pharma firm

2018-06-01 freepressjournal.in
New Delhi: The Enforcement Directorate has attached Rs 4,701 crore worth of assets of Gujarat-based pharmaceutical company Sterling Biotech Group in connection with a Rs 5,000 crore bank fraud money laundering case, the agency said today.
SLTHY STERLINBIO 512299 532480 532418 ALBK 532505 UCOBANK ANDHRABANK SBAZ

0
Three more cos under SFIO lens

2018-05-15 freepressjournal.in
New Delhi : The Serious Fraud Investigation Office (SFIO) is probing three companies — Ruchi Soya, Sterling Biotech and Kanishk Gold — that are already under the regulatory scanner for loan defaults, according to an official source.
SLTHY STERLINBIO RUCHISOYA 512299 500368

0
Sterling Biotech Limited - News Clarification

2018-05-14 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
SLTHY STERLINBIO 512299

0
Sterling Biotech Limited - News Clarification

2018-05-14 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
SLTHY STERLINBIO 512299

0
Andhra Bank files insolvency plea against Sterling

2018-05-12 freepressjournal.in
Mumbai : Andhra Bank has filed an insolvency plea against Sterling Biotech with the Mumbai bench of National Company Law Tribunal as the pharmaceutical company defaulted on payment of Rs 4,000 crore in dues.
SLTHY STERLINBIO 512299 532418 ANDHRABANK

8
Doubts linger on Rajiv Kochhar role in ICICI Bank loan mess

2018-04-03 freepressjournal.in
Mumbai : Media is thick with reports about investigations being undertaken about financial affairs at ICICI Bank. It is now the turn of the Central Bureau of Investigation (CBI) to begin questioning of not just ICICI Bank officials but also the Kochhars — Chanda and her husband, Deepak. But there is one more Kochhar whose activities in the financial markets may be worth investigating. The person is Rajiv Kochhar, Deepak Kochhar’s brother.
JIPKY IBN 512299 532418 532627 JPASSOCIAT 532532 ICICIBANK SLTHY STERLINBIO 532174 JPPOWER ANDHRABANK SBAZ

0
Nirav Modi, Vijay Mallya, and 29 other Indian fugitives owe Rs40,000 crore

2018-03-24 livemint
Mumbai: Even as harsh legislation to punish fugitive economic offenders takes shape in India, 31 individuals accused of fraud and economic offences are holed up abroad, the ministry of external affairs said.
533180 PNJZY SLTHY 532461 STERLINBIO 512299 SGJHL PNB

24
News Live: HC refuses to ground entire fleet of IndiGo#39;s A320neo aircraft

2018-03-16 moneycontrol
Walmart is in discussions to spend about $7 billion to become the largest investor in Flipkart, sources told Bloomberg, a move that would put the US retailer in competition with Amazon.com. It plans to buy about a third of Flipkart Online Services Pvt, in part by purchasing stakes from Tiger Global Management and SoftBank Group Corp, sources said.
500325 TTML 532915 RELIANCE 512299 RELIGARE SFTBF BHRQY 533278 500470 SLTHY STERLINBIO 532461 RIGD BHARTIARTL CLNDY SFTBY RLNIY YESBANK EDELWEISS 532648 YYBKY 532922 532843 532454 TTST PNJZY TATASTEEL FORTIS TATLY 532371 PNB 9984 COALINDIA

24
News Live: HC refuses to ground entire fleet of IndiGo#39;s A320neo aircraft; Daler Mehndi gets 2yr jail for human trafficking

2018-03-16 moneycontrol
Walmart is in discussions to spend about $7 billion to become the largest investor in Flipkart, sources told Bloomberg, a move that would put the US retailer in competition with Amazon.com. It plans to buy about a third of Flipkart Online Services Pvt, in part by purchasing stakes from Tiger Global Management and SoftBank Group Corp, sources said.
500325 TTML 532915 RELIANCE 512299 RELIGARE SFTBF BHRQY 533278 500470 SLTHY STERLINBIO 532461 RIGD BHARTIARTL CLNDY SFTBY RLNIY YESBANK EDELWEISS 532648 YYBKY 532922 532843 532454 TTST PNJZY TATASTEEL FORTIS TATLY 532371 PNB 9984 COALINDIA

21
News Live: Walmart may acquire majority stake in Flipkart for $7bn

2018-03-16 moneycontrol
Walmart is in discussions to spend about $7 billion to become the largest investor in Flipkart, sources told Bloomberg, a move that would put the US retailer in competition with Amazon.com. It plans to buy about a third of Flipkart Online Services Pvt, in part by purchasing stakes from Tiger Global Management and SoftBank Group Corp, sources said.
TTML 532915 512299 RELIGARE SFTBF BHRQY 533278 500470 SLTHY STERLINBIO 532461 BHARTIARTL CLNDY SFTBY YESBANK EDELWEISS 532648 YYBKY 532922 532843 532454 TTST PNJZY TATASTEEL FORTIS TATLY 532371 PNB 9984 COALINDIA

25
News Live: Yes Bank sells 2.17% stake in Fortis Healthcare, cos promoter hldg falls to 5.87% from 34.43%

2018-03-16 moneycontrol
Private sector lender Yes Bank has sold 2.17% stake in Fortis Healthcare, out of the over 17% stake it acquired last month. In a regulatory filing, the bank said it had sold 1.12 crore shares representing 2.17% stake of Fortis Healthcare in the open market between February 23 and March 15.
VTBR TTML 532915 512299 RELIGARE 36GK BHRQY 533278 500470 SLTHY STERLINBIO 532461 HDFCBANK BHARTIARTL CLNDY YESBANK EDELWEISS 532648 YYBKY 532922 532843 532454 TTST PNJZY TATASTEEL FORTIS TATLY HDB 500180 532371 PNB COALINDIA

22
News Live: Tibet can exist with China like #39;European Union#39;, says Dalai Lama

2018-03-16 moneycontrol
TDP leader Thota Narasimham moved a no-confidence motion in the Lok Sabha, hours after party president N Chandrababu Naidu announced in Amaravati that the party was exiting the National Democratic Alliance, reports PTI. "We go according to principles. Our leader felt being part of NDA and moving a no-confidence motion would not be ethical. So we withdrew from the NDA and I have issued a letter on no-confidence motion to the speaker at 9.
VTBR TTML 532915 512299 RELIGARE 36GK BHRQY 533278 500470 SLTHY STERLINBIO 532461 HDFCBANK BHARTIARTL CLNDY EDELWEISS 532922 532454 TTST PNJZY TATASTEEL TATLY HDB 500180 532371 PNB COALINDIA

Related Articles

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

ECYT: Endocyte Analysis and Research Report

2018-08-13 - Asif

Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...